
Zolbetuximab (VYLOY) Offers Fresh Chance in Late-Stage Stomach Cancer in Singapore
Zolbetuximab, a new targeted therapy, has just been approved in Singapore to treat certain types of advanced stomach and gastroesophageal cancers, bringing new hope to patients who previously had few options after diagnosis. In its early stages, gastric …